REFRACTORY UROTHELIAL CARCINOMA

Clinical trials for REFRACTORY UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

New drug combo battles tough bladder cancer when other treatments fail

Disease control Ongoing

This study is for people with advanced bladder cancer that has spread and is no longer responding to standard immunotherapies. It compares a new two-drug chemotherapy combination (eribulin plus gemcitabine) against the doctor's usual choice of chemotherapy. The main goal is to se…

Matched conditions: REFRACTORY UROTHELIAL CARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

REFRACTORY UROTHELIAL CARCINOMA

Get alerted when new REFRACTORY UROTHELIAL CARCINOMA trials appear

New drug combo battles tough bladder cancer when other treatments fail